Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Probiotics Administered as an Adjuvant Therapy in Pathological Neonatal Unconjugated Hyperbilirubinemia

NCT06449508 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06449508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06449508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Probiotics Administered as an Adjuvant Therapy in Pathological Neonatal Unconjugated Hyperbilirubinemia
Lead sponsor
Tanta University
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 1, 2024
Completion date
July 1, 2025
Enrollment
44 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

jaundice, neonatal